New Report Highlights Pricing, Reimbursement for Innovative Drugs

February 4, 2020

A new FirstWord report shifts the spotlight to pricing and reimbursement for innovative drugs in major non-U.S. markets.

The report, “Innovative drugs: Mapping the Pricing and Reimbursement Landscape (2020),” includes pricing, reimbursement and HTA data on 68 products.

To learn more about this report, click here.

Share This Story!